| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/07/2013 | US20130295656 Anaplasma Translocated Substrate-1 (Ats-1) and Sero-detection of Anaplasma phagocytophilum |
| 11/07/2013 | US20130295653 Integrated active flux microfluidic devices and methods |
| 11/07/2013 | US20130295641 Production of Conjugates |
| 11/07/2013 | US20130295601 Systems and Methods for Testing Drugs and Drug Delivery Systems |
| 11/07/2013 | US20130295594 Methods and compositions for the diagnosis of crohn's disease |
| 11/07/2013 | US20130295593 Truncated human vitamin d binding protein and mutation and fusion thereof and related materials and methods of use |
| 11/07/2013 | US20130295592 Determination of total analyte concentration |
| 11/07/2013 | US20130295591 Systems for immunoassay tests |
| 11/07/2013 | US20130295590 Foxa1 as a marker for invasive bladder cancer |
| 11/07/2013 | US20130295589 Ngal for diagnosis of renal conditions |
| 11/07/2013 | US20130295587 Method of coupling binding agents to a substrate surface |
| 11/07/2013 | US20130295586 Preparation of nanocrystals with mixtures of organic ligands |
| 11/07/2013 | US20130295584 Histone protein ubiquitination as a cancer biomarker |
| 11/07/2013 | US20130295583 Method to Increase Specificity and/or Accuracy of Lateral Flow Immunoassays |
| 11/07/2013 | US20130295582 Pan-kinase activation and evaluation of signaling pathways |
| 11/07/2013 | US20130295581 Methods and Compositions for the Treatment and Diagnosis of Breast Cancer |
| 11/07/2013 | US20130295580 Oral cancer point of care diagnostics |
| 11/07/2013 | US20130295578 Methods for screening for drug resistance in cancer treatment |
| 11/07/2013 | US20130295571 Marker of breast tumors from the luminal-b subtype |
| 11/07/2013 | US20130295561 Methods of enriching fetal cells |
| 11/07/2013 | US20130295553 Compositions and methods relating to mouse papilloma virus |
| 11/07/2013 | US20130295198 Methods of screening chemotherapeutic agents and treating cancer |
| 11/07/2013 | US20130295125 Compositions and methods relating to mouse papilloma virus |
| 11/07/2013 | US20130295123 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy |
| 11/07/2013 | US20130295115 Compositions and methods for treating alphavirus infection |
| 11/07/2013 | US20130295103 Antibodies against a proliferating inducing ligand (april) |
| 11/07/2013 | US20130295102 Compositions and methods for antibodies targeting factor p |
| 11/07/2013 | US20130295099 N-linkedglycan compounds |
| 11/07/2013 | US20130295075 Compositions and methods of treating glaucoma |
| 11/07/2013 | US20130295050 Anti-igf-i receptor antibodies, dnas, vectors, host cells and genetic constructs |
| 11/07/2013 | US20130295021 Human anti-tau antibodies |
| 11/07/2013 | US20130295007 Anti-pmel17 antibodies and immunoconjugates |
| 11/07/2013 | US20130294983 Methods And Apparatus For Isolating Platelets From Blood |
| 11/07/2013 | US20130294972 Zero-mode waveguide for single biomolecule fluorescence imaging |
| 11/07/2013 | US20130292570 System and method for performing heater-less lead selenide-based capnometry and/or capnography |
| 11/07/2013 | US20130292266 Devices and methods relating to electrochemical biosensors |
| 11/07/2013 | US20130291662 Chemical detection device having multiple flow channels |
| 11/07/2013 | US20130291632 Vessel inspection apparatus and methods |
| 11/07/2013 | US20130291628 Microparticle detecting apparatus |
| 11/07/2013 | US20130291622 Gas flux measurement system and method |
| 11/07/2013 | US20130291618 Calibratable sensor unit for reaction vessels |
| 11/07/2013 | US20130291617 Liquid level and composition sensing systems and methods using emf wave propagation |
| 11/07/2013 | DE10231269B4 Bestimmung der Gasbeschaffenheit von Brenngasen durch Messung von Wärmeleitfähigkeit, Wärmekapazität und Kohlendioxidanteil Determination of the gas composition of fuel gases by measuring thermal conductivity, heat capacity and carbon dioxide content |
| 11/07/2013 | DE102012207270A1 Diagnoseanordnung zum Bestimmen eines Alterungszustands einer elektrischen Komponente Diagnosis means for determining an aging state of an electrical component |
| 11/07/2013 | DE102012207240A1 Laser-micro dissection device for use in e.g. inverse microscope for dissection of human tissue sample for cell culture, has z-adjustment device and optical focus displacement device controlled together by optical laser-scanning device |
| 11/07/2013 | DE102012206042B4 Verfahren und Vorrichtung zur gezielten Prozessführung in einem Mikrofluidik-Prozessor mit integrierten aktiven Elementen Method and apparatus for selective process control in a microfluidic processor with integrated active elements |
| 11/06/2013 | EP2660606A1 Blood glucose measuring device |
| 11/06/2013 | EP2660605A1 Portable communication device, control method, and voice output system |
| 11/06/2013 | EP2660604A2 Immunogenic Streptococcus proteins |
| 11/06/2013 | EP2660603A1 Immunological assay method |
| 11/06/2013 | EP2660602A1 Test kit for lab diagnostics |
| 11/06/2013 | EP2660601A2 Methods for detecting molecular interactions |
| 11/06/2013 | EP2660600A1 Diagnostic drug and diagnostic method for alzheimer's disease |
| 11/06/2013 | EP2660599A1 Predicting risk of major adverse cardiac events |
| 11/06/2013 | EP2660598A1 Method for imaging and differential analysis of cells |
| 11/06/2013 | EP2660597A1 Method for assessing status of oral cavity, in addition to analytical device, apparatus and program therefor |
| 11/06/2013 | EP2660596A1 Health test for a broad spectrum of health problems |
| 11/06/2013 | EP2660595A1 Method for measurement of fat solubility |
| 11/06/2013 | EP2660594A1 Electronic apparatus for tracking vinification |
| 11/06/2013 | EP2660593A2 Determination of levels of immunogenic gluten peptides in human samples |
| 11/06/2013 | EP2660592A2 Method for selecting cereal seeds suitable for consumption by coeliac patients |
| 11/06/2013 | EP2660482A1 Apparatus, system, and method using immiscible-fluid-discrete-volumes |
| 11/06/2013 | EP2660320A1 Modified tamavidin |
| 11/06/2013 | EP2660249A1 Peptide derivative and use thereof |
| 11/06/2013 | EP2659984A2 Apparatus for self-extracting cells using magnetic force and method for self-extracting cells using the same |
| 11/06/2013 | EP2659913A2 Method to identify p11 modulators |
| 11/06/2013 | EP2659910A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells |
| 11/06/2013 | EP2659898A1 Interferon production-inducing agent containing lactic acid bacteria |
| 11/06/2013 | EP2659893A2 T cell regulation |
| 11/06/2013 | EP2659884A2 Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 11/06/2013 | EP2659552A1 Hybrid single molecule imaging sorter |
| 11/06/2013 | EP2659527A1 A platform comprising an organic field-effect transistor for biological and medical applications |
| 11/06/2013 | EP2659501A2 Quantitation of insulin by mass spectrometry |
| 11/06/2013 | EP2659275A2 Detection of a polypeptide dimer by a bivalent binding agent |
| 11/06/2013 | EP2659274A1 Luminescent composition as biomarker in a bird's egg, corresponding device and method |
| 11/06/2013 | EP2659273A1 Monoclonal antibodies against alpha-actinin-4 antigens, and uses therefor |
| 11/06/2013 | EP2659272A2 Protein biomarkers of recurrent breast cancer |
| 11/06/2013 | EP2659271A1 Therapeutic and diagnostic methods involving biglycan and utrophin |
| 11/06/2013 | EP2659270A2 Comprehensive monoclonal antibody generation |
| 11/06/2013 | EP2659269A1 Detection of a posttranslationally modified polypeptide by a bi-valent binding agent |
| 11/06/2013 | EP2659268A1 Systems and methods for high accuracy analyte measurement |
| 11/06/2013 | EP2659267A1 Cmet protein srm/mrm assay |
| 11/06/2013 | EP2659265A2 Processes and systems for characterizing and blending refinery feedstocks |
| 11/06/2013 | EP2659001A1 Improved methods for determining cell viability using molecular nucleic acid-based techniques |
| 11/06/2013 | EP2659000A1 Enhanced deposition of chromogens utilizing pyrimidine analogs |
| 11/06/2013 | EP2658969A1 Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof |
| 11/06/2013 | EP2284266B1 siRNA targeting tp53 |
| 11/06/2013 | CN203275417U Immune colloidal gold reagent strip for qualitative and quantitative human chorionic gonadotropin detection |
| 11/06/2013 | CN203275416U In-vitro CA-125 detection kit |
| 11/06/2013 | CN203275415U Protein chip for detecting esophageal squamous carcinoma marker and kit thereof |
| 11/06/2013 | CN203275414U Rapidly-detected CA19-9 kit |
| 11/06/2013 | CN203275413U Rapidly-detected CA50 kit |
| 11/06/2013 | CN203275412U Kit for chemical luminescence immunoassay of CA242 (tumor marker) |
| 11/06/2013 | CN203275411U Efficient screening cover plate and screening box for monoclonal antibody hybridoma |
| 11/06/2013 | CN203275410U Zilpaterol chemiluminiscence quantitative assay kit |
| 11/06/2013 | CN203275409U Kit for detecting HBeAG (hepatitis Be antigen) in vitro |
| 11/06/2013 | CN203275408U Kit for detecting free prostate specific antigen |
| 11/06/2013 | CN203275407U Detection kit for seven liver functions in serum |
| 11/06/2013 | CN203275406U Detection kit for renal functions in serum |
| 11/06/2013 | CN203275405U Whole blood cell analysis integrated device |